Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.

Ohashi, M

Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism. [electronic resource] - Japanese journal of cancer research : Gann Sep 1995 - 819-27 p. digital

Publication Type: Journal Article

0910-5050

10.1111/j.1349-7006.1995.tb03091.x doi


Animals
Antimetabolites, Antineoplastic--pharmacology
Apoptosis--drug effects
CDC2-CDC28 Kinases
Carcinoma, Lewis Lung--drug therapy
Cell Death--drug effects
Cell Division--drug effects
Colonic Neoplasms--drug therapy
Cyclin-Dependent Kinase 2
Cyclin-Dependent Kinases--antagonists & inhibitors
Ellipticines--pharmacology
Enzyme Inhibitors--pharmacology
Histones--metabolism
Humans
Mice
Mice, Inbred Strains
Microsomes--drug effects
Phosphorylation--drug effects
Precipitin Tests
Protein Serine-Threonine Kinases--antagonists & inhibitors
Topoisomerase II Inhibitors
Tumor Cells, Cultured
Tumor Suppressor Protein p53--metabolism